Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study-Reference-Cited by-同舟云学术

Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study

Published:2016-03 Issue: Volume:57 Page:23-29
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Taher Ali T.,Cappellini M. Domenica,Aydinok Yesim,Porter John B.,Karakas Zeynep,Viprakasit Vip,Siritanaratkul Noppadol,Kattamis Antonis,Wang Candace,Zhu Zewen,Joaquin Victor,Uwamahoro Marie José,Lai Yong-Rong

Funder

Novartis Pharma AG

Novartis Pharmaceuticals

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference30 articles.

1. Beta-thalassemia;Galanello;Orphanet J Rare. Dis,2010

2. Hemoglobin E syndromes;Vichinsky;Hematology Am. Soc. Hematol. Educ. Program,2007

3. Hb H disease: clinical course and disease modifiers;Fucharoen;Hematology Am. Soc. Hematol. Educ. Program,2009

4. Alpha-thalassaemia;Harteveld;Orphanet J. Rare Dis.,2010

5. The definition and epidemiology of non-transfusion-dependent thalassemia;Weatherall;Blood Rev.,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deferoxamine and other iron chelators;Encyclopedia of Toxicology;2024

2. Antioxidant Effects of Argan Oil and Olive Oil against Iron-Induced Oxidative Stress: In Vivo and In Vitro Approaches;Molecules;2023-08-07

3. Iron chelation therapy;European Journal of Haematology;2023-02-08

4. Non-Transfusion-Dependent Thalassemia: A Panoramic Review;Medicina;2022-10-21

5. An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results;American Journal of Hematology;2022-05-27